Can DMARDs be stopped in patients with stable RA?
Trial findings suggest patients in remission might benefit from a more flexible approach to management of therapy, researchers say.
Tag: Pharma interest
Pausing mycophenolate ‘boosts COVID-19 vax response’
Patients are nearly six times more likely to make antibodies to the SARS-CoV-2 spike protein if taken off the therapy, researchers say.
The rise and dramatic fall of COVID-19 convalescent plasma therapy
Early in the pandemic, scientists thought convalescent plasma might be a way to treat COVID-19. By giving patients the plasma of people who had recovered…
Are two antiandrogens better than one in metastatic prostate cancer?
Final results of the ACIS study in patients with castration-resistant disease show a benefit in radiographic progression-free survival.
Is the new COVID-19 pill really a game changer?
Virologist Dr Vinod Balasubramaniam explains the interim trial results of the therapy in patients with mild to moderate disease.
A GP guide to vaping and nicotine prescribing
With recent changes to TGA regulations, GPs are likely to see an increasing number of patients seeking advice on vaping and nicotine prescriptions.…
So what are ‘needle pills’ and why would doctors use them?
A tortoise has inspired an experimental drug-delivery device.
TGA warns of ‘serious shortages’ in key angina drugs
Supply issues affect two brands of isosorbide mononitrate 120mg modified release tablets.
Llamas may hold key to COVID-19 therapy
The cute camelids have unusually small antibodies which are 'effective' at neutralising SARS-CoV-2.
A patient overdosed on ivermectin – here’s what to look out for
Westmead Hospital in Sydney’s west says it has treated a patient who overdosed after taking the drug ivermectin, an unproven and potentially dangerous treatment for…
